Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ecklonia cava, a brown seaweed, is rich in unique phlorotannins such as dieckol, which provide potent antioxidant and anti-inflammatory benefits. These compounds also support cardiovascular health by inhibiting ACE and promoting vasodilation through the PI3K/Akt/eNOS pathway.
Reported Benefits (Provisional)
Origin & History
Ecklonia cava is a brown seaweed (Phaeophyceae) native to the nutrient-rich coastal waters of Japan, Korea, and China. Revered in marine pharmacology, it is distinguished by its unique phlorotannin compounds, which are exclusive to marine algae. This powerful botanical is highly valued in functional nutrition for its potent antioxidant, anti-inflammatory, neuroprotective, and cardiovascular benefits.
Research Narrative (Provisional)
Extensive research, including in vitro and animal studies, supports Ecklonia cava's potent antioxidant and anti-inflammatory properties, primarily attributed to its unique phlorotannins. Studies highlight its significant neuroprotective, cardioprotective, and anti-aging benefits. While promising, more human clinical trials are needed to confirm optimal dosages and long-term efficacy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Phlorotannins (unique marine polyphenols with neuroprotective, anti-aging properties), Fucoidan (sulfated polysaccharide with anti-inflammatory, heart-supportive effects). - Vitamins: Vitamin E (skin integrity, antioxidant defense). - Minerals: Iodine (thyroid hormone regulation, metabolic activity).
Reported Mechanism (Provisional)
Ecklonia cava's primary bioactive compounds, phlorotannins like dieckol and eckol, exert their effects through multiple pathways. They inhibit angiotensin-converting enzyme (ACE), blocking angiotensin II production to lower blood pressure, and activate the PI3K/Akt/eNOS pathway, which promotes nitric oxide synthesis and vasodilation. Furthermore, these phlorotannins effectively scavenge reactive oxygen species (ROS), thereby mitigating oxidative stress and systemic inflammation.
Clinical Narrative (Provisional)
Research on Ecklonia cava primarily consists of in vitro and animal studies, demonstrating its significant antioxidant and anti-inflammatory properties, attributed to its unique phlorotannins. These studies have shown promising results in areas such as neuroprotection, cardioprotection, and anti-aging, indicating its potential to enhance cognitive function and cardiovascular health. While the findings are encouraging, more extensive human clinical trials are necessary to fully establish efficacy, optimal dosages, and long-term safety in diverse populations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.